An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum

Clinical trial NCT02199925 · UNKNOWN

Trial details

NCT number: NCT02199925
Sponsor: Isaac Melamed
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Autism Autistic Disorder Asperger's Disorder PDD Pervasive Developmental Disorder

Start date: 2013-06-01
Primary completion: 2015-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.